DOD - Department of Defense

A Druggable Epigenetic Vulnerability Pathway in p53-deficient Hepatocellular Carcinoma

A Novel Therapeutic Approach for Treating WNT-Driven Hepatocellular Carcinoma

A Targeted Mitochondrial Luminoptogenetic Gene Therapy to Treat Triple Negative Breast Cancer

A Targeted Mitochondrial Luminoptogenetic Gene Therapy to Treat Triple Negative Breast Cancer

Assessing Neuroinflammation in Gulf War Illness with Whole-Brain Magnetic Resonance Spectroscopy

Boosting the Systemic and in Situ CD4+ T-Cell Responses to Malignant Glioma by Oncolytic HSV Virotherapy

Clinical Trial Award - Selumentinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Young Children with Neurofibromatosis Type 1 (NF1)

Collapsing the Tumor-Supportive Immune Portfolio of Breast Cancer to Achieve Durable Reduction of Metastasis

DNA Damage as a Predictive Biomarker for Immunotherapy Response in Ovarian Cancer

Development of a Gut Microbiome Based Prognostic Signature Predicting Risk of Hepatocellular Cancer Recurrence After Ablative Therapies

Dual PET/Fluorescence Imaging of Glioma with an MMP-14 Activabable Peptide Probe

Effects of ITGAM Genetic Variation on Mac-1 Mediated Functions of B Cells

Elevated Uracil Glycosylase Coupled to Reduced Base Excision Repair Promotes AA PCa Progression

Evaluation Of A Novel Hemostatic Agent In Junctional Trauma

Evaluation of NADPH Oxidase 1/4 Inhibition as a Novel Therapeutic Strategy Against Chronic Pancreatitis

Evaluation of Pirfenidone as a Therapy in Patients with Predicted Moderate to Severe Acute Pancreatitis

Glycocalyx Mechanoregulation of Anglopoietln-2 and Post-Traumatic Lung Injury

Gut Microbiome as a Predictor of Response to Chemotherapy in Metastatic Colorectal Cancer

IPA - Robert Meakin

IPA Robert Meakin

Immersive Virtual Walking as Treatment for Neuropathic Pain in Spinal Cord Injury: Examing Treatment Efficacy and Cortical Mechanisms

Improving Immune Response in Ovarian Cancer by Modulating the Wnt Pathway

Interactions of Gut Microbiome, Genetic Susceptibility and Environmental Factors in Parkinson's Disease

Interactions of Gut Microbiome, Genetic Susceptibility and Environmental Factors in Parkinson's Disease

Investigating the Expression, Role and Targeting of Collagen Modifying Prolyl 4-hydroxylase P4HA1 in Prostate Cancer Progression and Metastasis

Meaningful Changes in Fitness, Functional Independence, and Transfer Independence ss Defined by Individuals Living with Spinal Cord Injury

Oncobioenergetics of Breast Carcinogenesis

Overcoming PAAP Inhibitor Resistance of BACA-Deficient Ovarian Cancers

PAI-1 and Lung Fibrosis: Mechanisms and Therapeutics

PAI-1 and Lung Fibrosis: Mechanisms and Therapeutics

Part B - Surviving Blood Loss: First in Human Studies to Assess Safety and Physiological Effects of Synthetic Ethinyl Estradiol-3-Sulfate (EE·3·SO4) in Healthy Subjects, Both Euvolemic and Following 10-20% Iatrogenic Blood Loss

Pharmacological Management of Ultraviolet Radiation Induced Skin Cancer

Quantitative CT Biomarkers to Predict Metastatic RCC Response to Anti-Angiogenic Therapy

Role of Exostosin-1 in Regulating Hemorrhage-Induced Microvascular Dysfunction and Lung Injury

Sculpting Anti-tumor Immunity as an Approach to Treat Metastatic Breast Cancer

Skin Grafting From ‘9-Gene’ Genetically Engineered Pigs in the Treatment of Burns: An Experimental Study in Monkeys.

Skin Grafting from 9-Gene Genetically Engineered Pigs in the Treatment of Burns: An Experimental Study in Monkeys

Skin Grafting from 9-Gene Genetically Engineered Pigs in the Treatment of Burns: An Experimental Study in Monkeys

Targeting Homology-Directed Recombinational Repair (HDR) of Chromosomal Breaks to Sensitize Prostate Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibition

Targeting The CD24 Signaling for Lethal Metastatic Prostate Cancer Therapy

The Neurofibromatosis Clinical Trials Consortium

Therapeutic Recovery of Immune and Lung Tissue Bioenergetic Homeostasis in Sepsis-Induced Immunosuppression

Using Early Time-Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults with Type 2 Diabetes